Redcare Pharmacy NV (ETR:RDC)
Germany · Delayed Price · Currency is EUR 52.35
-2.55 (-4.64%)
Sep 11, 2026, 5:35 PM CET
Redcare Pharmacy NV Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Redcare Pharmacy NV stock has a consensus rating of "Buy" and an average price target of €87.50. The average 1-year stock price forecast is 67.14% higher than the current stock price, while the lowest is €55.00 (+5.06%) and the highest is €116.00 (+121.59%).
Price Target: €87.50 (+67.14%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Redcare Pharmacy NV stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains €97.00 | Buy | Maintains | €97.00 | +85.29% | Sep 3, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Maintains €103.00 | Buy | Maintains | €103.00 | +96.75% | Sep 1, 2026 |
| Barclays | Barclays | Buy Reiterates €85.00 | Buy | Reiterates | €85.00 | +62.37% | Aug 12, 2026 |
| UBS | UBS | Hold Maintains €60.00 → €74.00 | Hold | Maintains | €60.00 → €74.00 | +41.36% | Jul 31, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Maintains €92.00 → €94.00 | Buy | Maintains | €92.00 → €94.00 | +79.56% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
3.43B
from 2.94B
Increased by 16.54%
Revenue Next Year
3.83B
from 3.43B
Increased by 11.82%
EPS This Year
-0.35
from -1.40
EPS Next Year
1.19
from -0.35
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.